CRMX Strangle Strategy

CRMX (Tradr 2X Long CRML Daily ETF), in the Financial Services sector, (Asset Management - Leveraged industry), listed on CBOE.

CRMX is an intraday tactical investment vehicle, specifically designed to provide twice (200%) the daily price performance of Critical Metals Corp. (CRML), before accounting for management fees and operational expenses. The fund's core strategy involves engaging in total return swap agreements with prominent global financial institutions, which are structured to mirror CRML's daily movements. In scenarios where swaps are either unavailable or less efficient, the fund retains the flexibility to utilize FLEX call options or, alternatively, hold CRML common stock directly. Crucially, investors who intend to hold shares for longer than a single trading day must be prepared to frequently monitor and rebalance their positions to maintain the targeted 2x daily leverage. Due to the inherent complexities of this product, its optimal performance is typically observed when the underlying CRML shares exhibit a sustained upward trend, and the investor's market direction aligns with that trend. Prospective investors are strongly advised to conduct their own comprehensive individual stock research prior to initiating any position and to invest with a well-informed strategy.

CRMX (Tradr 2X Long CRML Daily ETF) trades in the Financial Services sector, specifically Asset Management - Leveraged, with a market capitalization of approximately $1.0M, a beta of 9.04 versus the broader market, a 52-week range of 3.19-144.33, average daily share volume of 264K, a public-listing history dating back to 2026. These structural characteristics shape how CRMX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 9.04 indicates CRMX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a strangle on CRMX?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

CRMX snapshot

As of August 14, 2026, spot at $5.17, ATM IV 222.70%, IV rank 51.29%, expected move 63.85%. The strangle on CRMX below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this strangle structure on CRMX specifically: CRMX IV at 222.70% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 63.85% (roughly $3.30 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRMX expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRMX should anchor to the underlying notional of $5.17 per share and to the trader's directional view on CRMX stock.

CRMX strangle setup

The CRMX strangle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRMX at $5.17 on that close, the first option leg uses a $5.43 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRMX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRMX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$5.43N/A
Buy 1Put$4.91N/A

CRMX strangle risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

CRMX strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on CRMX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on CRMX

Strangles on CRMX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CRMX chain.

CRMX thesis for this strangle

The market-implied 1-standard-deviation range for CRMX extends from approximately $1.87 on the downside to $8.47 on the upside. A CRMX long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CRMX IV rank near 51.29% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on CRMX should anchor more to the directional view and the expected-move geometry. As a Financial Services name, CRMX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRMX-specific events.

CRMX strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRMX positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRMX alongside the broader basket even when CRMX-specific fundamentals are unchanged. Always rebuild the position from current CRMX chain quotes before placing a trade.

Frequently asked questions

What is a strangle on CRMX?
A strangle on CRMX is the strangle strategy applied to CRMX (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CRMX stock at $5.17 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed CRMX chain strike and the premiums come straight from that session's bid/ask midpoint.
How are CRMX strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CRMX strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 222.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CRMX strangle?
The breakeven for the CRMX strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CRMX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 63.85%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on CRMX?
Strangles on CRMX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CRMX chain.
How does current CRMX implied volatility affect this strangle?
CRMX ATM IV is at 222.70% with IV rank near 51.29%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related CRMX analysis